The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

Resultado final

Website with name, logo, project description, and partner information available, plus posting of recent advances and upcoming events online.

Clinical case reports from all affiliated centers treating Long-COVID patients

Provide clinical evidence and specification of patient cohort disease criteria.

Publicaciones

International Journal of Molecular Sciences

Autores: Arora et al.
Publicado en: International Journal of Molecular Sciences, 2023, ISSN 1422-0067
Editor: Basel MDPI Center 2000-
DOI: 10.3390/ijms232214057

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread

Autores: Casanova & Abel
Publicado en: Cell, 2022, ISSN 1097-4172
Editor: Cell
DOI: 10.1016/j.cell.2022.07.004

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Autores: Zhang et al.
Publicado en: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editor: Rockefeller University Press
DOI: 10.1084/jem.20220131

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

Autores: Arora et al.
Publicado en: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Editor: The Lancet
DOI: 10.1016/S1473-3099(22)00831-3

Human inherited complete STAT2 deficiency underlies inflammatory viral diseases

Autores: Bucciol et al.
Publicado en: Journal of Clinical Investigation, 2023, ISSN 1558-8238
Editor: American Society for Clinical Investigation
DOI: 10.1172/JCI168321

Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

Autores: Arora et al.
Publicado en: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Editor: The Lancet
DOI: 10.1016/S1473-3099(22)00591-6

Pharmaceuticals

Autores: Centofanti et al.
Publicado en: Pharmaceuticals (Basel), 2024, ISSN 1424-8247
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ph16020240

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

Autores: Lee et al.
Publicado en: Science, 2022, ISSN 1095-9203
Editor: Science
DOI: 10.1126/science.abo3627

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Autores: Zhang et al.
Publicado en: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editor: Rockefeller University Press
DOI: 10.1084/jem.20220514

Pathogens

Autores: Skouboe et al.
Publicado en: Pathogens, 2022, ISSN 2076-0817
Editor: Basel MDPI AG 2012-
DOI: 10.3390/pathogens12020310

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Autores: Budhadev et al.
Publicado en: JACS Au, 2023, ISSN 2691-3704
Editor: Washington, DC American Chemical Society [2021]-
DOI: 10.1021/jacsau.3c00163

Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity

Autores: Tangye et al.
Publicado en: Journal of Allergy and Clinical Immunology, 2022, ISSN 2772-8293
Editor: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2022.11.010

Nature Communications

Autores: Hoffmann et al.
Publicado en: Nature Communications, 2023, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-023-39147-4

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs

Autores: von Gunten et al.
Publicado en: Frontiers in Immunology, 2023, ISSN 2832-4404
Editor: Lausanne Frontiers Media S.A. 2010-
DOI: 10.48350/181810

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies

Autores: Arora et al.
Publicado en: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Editor: The Lancet
DOI: 10.1016/S1473-3099(22)00733-2

The genetic and evolutionary determinants of COVID-19 susceptibility

Autores: Kerner et al.
Publicado en: European Journal of Human Genetics, 2022, ISSN 1476-5438
Editor: Nature
DOI: 10.1038/s41431-022-01141-7

COVID-19: S-Peptide RBD 484–508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients

Autores: Murdocca et al.
Publicado en: Viruses, 2023, ISSN 1999-4915
Editor: Basel MDPI 2009-
DOI: 10.3390/v15071417

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

Autores: Mathian et al.
Publicado en: Annals of the Rheumatic Diseases, 2022, ISSN 1468-2060
Editor: BMJ Group on behalf of the European League Against Rheumatism
DOI: 10.1136/ard-2022-222549

Viruses

Autores: Campos-Gonzalez et al.
Publicado en: Viruses, 2024, ISSN 1999-4915
Editor: Basel MDPI 2009-
DOI: 10.3390/v15030789

Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

Autores: Zhang et al.
Publicado en: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Editor: Elsevier
DOI: 10.1016/S1473-3099(23)00547-9

Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

Autores: Bucciol et al.
Publicado en: Journal of Allergy and Clinical Immunology, 2023, ISSN 2772-8293
Editor: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2023.02.003

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

Autores: Sokal et al.
Publicado en: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editor: Rockefeller University Press
DOI: 10.1084/jem.20220258

Resultado final

Publicaciones

Compartir esta página

Descargar